Stokkel MPM - Search Results

1

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.

van der Hiel B, Haanen JBAG, Stokkel MPM, Peeper DS, Jimenez CR, Beijnen JH, van de Wiel BA, Boellaard R, van den Eertwegh AJM; REPOSIT study group. van der Hiel B, et al. Among authors: stokkel mpm. BMC Cancer. 2017 Sep 15;17(1):649. doi: 10.1186/s12885-017-3626-5. BMC Cancer. 2017. PMID: 28915798 Free PMC article.

2

18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.

Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ. Stokkel MP, et al. Cancer. 1999 Dec 1;86(11):2370-7. Cancer. 1999. PMID: 10590380 Review.

3

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas.

van der Hiel B, Pauwels EK, Stokkel MP. van der Hiel B, et al. J Cancer Res Clin Oncol. 2001 May;127(5):269-77. doi: 10.1007/s004320000191. J Cancer Res Clin Oncol. 2001. PMID: 11355141 Review.

4

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.

Stokkel MP, Draisma A, Pauwels EK. Stokkel MP, et al. J Cancer Res Clin Oncol. 2001 May;127(5):278-85. doi: 10.1007/s004320000208. J Cancer Res Clin Oncol. 2001. PMID: 11355142 Review.

5

Effective treatment of bone metastases from a neuroendocrine tumour of the pancreas with high activities of Indium-111-pentetreotide.

van der Hiel B, Stokkel MP, Chiti A, Lucignani G, Bajetta E, Pauwels EK, Bombardieri E. van der Hiel B, et al. Eur J Endocrinol. 2003 Dec;149(6):479-83. doi: 10.1530/eje.0.1490479. Eur J Endocrinol. 2003. PMID: 14640987

6

Intermittent ST-segment depressions during adenosine stress test.

van der Hiel B, Scholte AJ, Stokkel MP. van der Hiel B, et al. Clin Nucl Med. 2007 Dec;32(12):927-9. doi: 10.1097/RLU.0b013e3181596664. Clin Nucl Med. 2007. PMID: 18030042

7

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.

Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA. Koolen BB, et al. Breast Cancer Res Treat. 2012 Jan;131(1):117-26. doi: 10.1007/s10549-011-1767-9. Epub 2011 Sep 21. Breast Cancer Res Treat. 2012. PMID: 21935602

8

FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.

Koolen BB, Vegt E, Rutgers EJ, Vogel WV, Stokkel MP, Hoefnagel CA, Fioole-Bruining A, Vrancken Peeters MJ, Valdés Olmos RA. Koolen BB, et al. Ann Nucl Med. 2012 Jan;26(1):86-91. doi: 10.1007/s12149-011-0538-3. Epub 2011 Sep 28. Ann Nucl Med. 2012. PMID: 21953212

9

Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.

Rietbergen DD, van der Hiel B, Vogel W, Stokkel MP. Rietbergen DD, et al. Nucl Med Commun. 2011 Dec;32(12):1143-7. doi: 10.1097/MNM.0b013e32834b76fa. Nucl Med Commun. 2011. PMID: 22045476

10

Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.

Stokkel MP, van der Hiel B, Olmos RV, Hoefnagel K. Stokkel MP, et al. Eur J Nucl Med Mol Imaging. 2012 May;39(5):919-20. doi: 10.1007/s00259-012-2068-1. Eur J Nucl Med Mol Imaging. 2012. PMID: 22286771 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters